Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas-Reference-Cited by-同舟云学术

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas

Published:2018-11-09 Issue:3 Volume:25 Page:1087-1097
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

de Jonge Marthe M.^ORCID,Auguste Aurélie,van Wijk Lise M.,Schouten Philip C.,Meijers Matty,ter Haar Natalja T.,Smit Vincent T.H.B.M.,Nout Remi A.^ORCID,Glaire Mark A.,Church David N.,Vrieling Harry,Job Bastien,Boursin Yannick^ORCID,de Kroon Cor D.,Rouleau Etienne^ORCID,Leary Alexandra,Vreeswijk Maaike P.G.,Bosse Tjalling

Funder

KWF Kankerbestrijding (Dutch Cancer Society)

Wellcome Trust

DH | National Institute for Health Research (NIHR)

Academy of medical sciences/ Health foundation clinician scientist fellowship

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic subtypes and cellular phenotypes of high-grade endometrial carcinoma;2024-09-04

2. Molecular pathology of endometrial cancer: recent advances in classification, prognostication, and management;Diagnostic Histopathology;2024-09

3. Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches;Frontiers in Oncology;2024-08-16

4. Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer;Cancer;2024-08-16

5. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging;Gynecologic Oncology;2024-07